Impact Assessment of COVID-19 Outbreak on Erectile Dysfunction Treatment Market

Erectile dysfunction, often known as impotence, is a medical disorder characterised by the inability to obtain and maintain a firm erection during sexual intercourse. The major reasons of erectile dysfunction are hormonal imbalance, insufficient blood supply to the penis, nervous system problems, and psychological causes such as despair and worry. Underlying medical issues such as excessive blood pressure and cardiovascular disease can also cause erectile dysfunction. External penile support devices, penile vibrators, and extracorporeal shockwave therapy have all been developed as a result of technological advancements in the field of erectile dysfunction.

The global erectile dysfunction treatment market is projected to be primarily driven by the high prevalence and rising incidences of erectile dysfunction. Around 50% of men aged 40 to 70 years are estimated to suffer from some degree of erectile dysfunction. Incidence of erectile dysfunction increases with the growing age. During the forecast period, this is expected to drive the erectile dysfunction treatment devices market. People who have risk factors related to their lifestyle, particularly chain smokers, are more prone to erectile dysfunction. Technological growth has resulted in the development of new products that are more efficient and provide high levels of user pleasure. During the forecast period, new product development and approvals for erectile dysfunction treatment, such as external penile support devices, are expected to drive the erectile dysfunction treatment devices market. However, the availability of therapeutic medications and the high cost of implanted devices are anticipated to limit the growth of the erectile dysfunction treatment devices market in the near future.

Based on geography, the global erectile dysfunction treatment devices market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are estimated to account for the leading share of the global erectile dysfunction treatment devices market during the forecast period. Currently, more than 18 million men in the U.S. are being affected by erectile dysfunction. This number is expected to rise over the years.